1.Effect evaluation of pharmaceutical service based on root cause analysis combined with KAP theory on decreasing the protocol violations of investigational medicinal products rate in pediatric clinical trials
Chunyan GUO ; Yi ZHANG ; Yuxin YANG ; Yuguang LIANG ; Qian DING ; Qian WANG ; Chengyue ZHANG ; Yu SUN ; Peng GUO
China Pharmacy 2026;37(9):1206-1210
OBJECTIVE To investigate the effect of pharmaceutical services guided by root cause analysis (RCA) in a problem-oriented manner combined with knowledge-attitude-practice (KAP) theory on reducing the incidence of protocol violations of investigational medicinal products in pediatric clinical trials. METHODS A total of 617 participants from 69 drug clinical trial projects conducted in our hospital from January 2016 to December 2020 were selected as the control group, and 868 participants from 72 drug clinical trial projects from January 2022 to December 2025 as the observation group. RCA was performed on the protocol violations of investigational medicinal product in the control group to identify the types and underlying causes. The control group received routine pharmaceutical services for drug clinical trials, while the observation group was provided with precision pharmaceutical services from the three dimensions of knowledge, attitude and practice on the basis of routine pharmaceutical services, according to the root causes identified by RCA. The occurrence of investigational medicinal products protocol violations was compared between the two groups. RESULTS The total incidence of protocol violations of investigational medicinal products, as well as the incidences of minor and major protocol violations, were all significantly lower in the observation group than in the control group ( P <0.001). The main types of protocol violations in both groups included missed/under-/over-dosing of medications, non-adherence to administration time, failure to adjust dosage as required, and combined medication/vaccination in violation of the protocol. Regarding the responsible subjects of protocol violations, the incidences of protocol violations attributed to participants and their guardians as well as investigators and accidental factors were significantly lower in the observation group than in the control group ( P <0.001, P <0.001, P =0.025). However, there were no statistically significant differences in the incidences of protocol violations caused by sponsor-related reasons between the two groups ( P >0.05). CONCLUSIONS Pharmaceutical services led by pharmacists, based on problem-oriented RCA and combined with KAP theory, can effectively reduce the protocol violations of investigational medicinal products rate in pediatric clinical trials, thereby safeguarding the safety and rights of study participants.
2.Exploration and practice on construction of clinical research integrated management system of a pediatric hospital in Beijing
Yuguang LIANG ; Qian WANG ; Qian DING ; Chunyan GUO ; Meng ZHANG ; Yi ZHANG ; Xiaoling WANG ; Peng GUO
Chinese Journal of Medical Science Research Management 2025;38(1):69-74
Objective:This study starts from the main problems existing in the current stage of the development of pediatric clinical research in China and focuses on the construction of a clinical research management system. By innovating the platform management model and enhancing personnel skills, we can provide support and assurance for improving the clinical research platform and its sustainable development in the future.Methods:This study established an integrated management platform for Industry-Sponsored Initiated Clinical Research Trial (IST) and Investigator Initiated Clinical Research (IIT) and implement integrated management of IST and IIT projects. At the same time, in response to the weak links in quality management, synchronous training of management and research talents should be implemented to achieve dual improvement in project management quality and platform service efficiency throughout the process.Results:We had optimized the clinical research organization structure, improved the management system, and strengthened the quality supervision of IIT projects by establishing rules and systems to improve the quality and efficiency of project management.Conclusions:Based on analyzing the current situation in China and referring to international experience, we have built a clinical research management platform in line with the development of the hospital, and implemented centralized management of the entire process of IST and IIT projects, strengthened project process quality control, which is expected to provide a reference for peers.
3.Exploration and practice on Investigator-Initiated high-risk trial management at a pediatric hospital in Beijing
Yuguang LIANG ; Chunyan GUO ; Qian DING ; Qian WANG ; Meng ZHANG ; Yi ZHANG ; Peng GUO
Chinese Journal of Medical Science Research Management 2025;38(5):442-448
Objective:In response to the current situation where Investigator-Initiated Trial (IIT) management system of pediatric medical institutions in our country is inadequate and the management of high-risk projects needs to be strengthened, a pediatric hospital in Beijing has been selected as a pilot to develop a system and process suitable for IIT management. We aim to explore personalized management models for different types of research projects, especially high-risk ones, to improve the quality of pediatric IIT, reduce research risks, and enhance management efficiency.Methods:By analyzing the current management situation of high-risk pediatric IIT, optimization strategies were proposed to improve the internal IIT project management system and processes of the pilot unit, and effective management measures are promoted.Results:By revising the IIT project management system, improving the project application and approval processes, strengthening process quality control and personnel training, the risk control and quality supervision of such projects had been enhanced, thereby improving project quality and ensuring the rights and interests of research participants.Conclusions:After the pilot unit trialed a series of management measures for high-risk IIT projects, researchers' risk awareness has significantly increased, and project quality has been effectively improved. The Results provide a reference and model for peers in establishing management rules and also offer theoretical and practical foundations for improving the management system of high-risk clinical research.
4.Theoretical Basis and Application Practice of Chiqilin Powder in the Treatment of Atherosclerosis
Bochao JIA ; Yuanhui HU ; Tao CHENG ; Chenlu YUAN ; Yi WEI ; Yuguang CHU ; Shuai SHI
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(2):499-504
Atherosclerosis(AS)is the important pathological foundation of cardiovascular and cerebrovascular diseases.There is a high degree of consistency between AS and yin-nature carbuncles in terms of etiology,disease-location,severity of illness,pathogenesis,therapies and progression of disease.Based on the theory of yin-nature carbuncles and after the analysis of the characteristics of zang-fu organs mainly involved in AS and the intricate pathogenesis of AS,this paper put forward the use of warming-eliminating,warming-expulsing and warming-tonifying therapies together for treating AS,and established Chiqilin Powder,the experienced prescription including triplet medicinals,i.e.,Notoginseng Radix et Rhizoma,Draconis Sanguis,and Fermentum Rubrum.In the prescription,Notoginseng Radix et Rhizoma mainly has the warming-tonifying and warming-expulsing actions,and also exerts the warming-eliminating actions;Draconis Sanguis exerts eliminating,expulsing and tonifying actions simultaneously;Fermentum Rubrum mainly has the warming-tonifying and warming-eliminating actions,and also exerts the warming-expulsing actions.In clinical practice,the application of Chiqilin Powder in the treatment of AS patients with yang deficiency and phlegm blended with blood stasis syndrome has achieved remarkable therapeutic effects,which will provide reference for the clinical use of Chinese herbal medicine in the treatment of AS.
5.Exploration and practice on construction of clinical research integrated management system of a pediatric hospital in Beijing
Yuguang LIANG ; Qian WANG ; Qian DING ; Chunyan GUO ; Meng ZHANG ; Yi ZHANG ; Xiaoling WANG ; Peng GUO
Chinese Journal of Medical Science Research Management 2025;38(1):69-74
Objective:This study starts from the main problems existing in the current stage of the development of pediatric clinical research in China and focuses on the construction of a clinical research management system. By innovating the platform management model and enhancing personnel skills, we can provide support and assurance for improving the clinical research platform and its sustainable development in the future.Methods:This study established an integrated management platform for Industry-Sponsored Initiated Clinical Research Trial (IST) and Investigator Initiated Clinical Research (IIT) and implement integrated management of IST and IIT projects. At the same time, in response to the weak links in quality management, synchronous training of management and research talents should be implemented to achieve dual improvement in project management quality and platform service efficiency throughout the process.Results:We had optimized the clinical research organization structure, improved the management system, and strengthened the quality supervision of IIT projects by establishing rules and systems to improve the quality and efficiency of project management.Conclusions:Based on analyzing the current situation in China and referring to international experience, we have built a clinical research management platform in line with the development of the hospital, and implemented centralized management of the entire process of IST and IIT projects, strengthened project process quality control, which is expected to provide a reference for peers.
6.Exploration and practice on Investigator-Initiated high-risk trial management at a pediatric hospital in Beijing
Yuguang LIANG ; Chunyan GUO ; Qian DING ; Qian WANG ; Meng ZHANG ; Yi ZHANG ; Peng GUO
Chinese Journal of Medical Science Research Management 2025;38(5):442-448
Objective:In response to the current situation where Investigator-Initiated Trial (IIT) management system of pediatric medical institutions in our country is inadequate and the management of high-risk projects needs to be strengthened, a pediatric hospital in Beijing has been selected as a pilot to develop a system and process suitable for IIT management. We aim to explore personalized management models for different types of research projects, especially high-risk ones, to improve the quality of pediatric IIT, reduce research risks, and enhance management efficiency.Methods:By analyzing the current management situation of high-risk pediatric IIT, optimization strategies were proposed to improve the internal IIT project management system and processes of the pilot unit, and effective management measures are promoted.Results:By revising the IIT project management system, improving the project application and approval processes, strengthening process quality control and personnel training, the risk control and quality supervision of such projects had been enhanced, thereby improving project quality and ensuring the rights and interests of research participants.Conclusions:After the pilot unit trialed a series of management measures for high-risk IIT projects, researchers' risk awareness has significantly increased, and project quality has been effectively improved. The Results provide a reference and model for peers in establishing management rules and also offer theoretical and practical foundations for improving the management system of high-risk clinical research.
7.Chronic Postsurgical Pain Among Patients with Preoperative COVID-19: An Ambispective Cohort Study
Lu CHE ; Jiawen YU ; Di JIN ; Xue BAI ; Yi WANG ; Yuelun ZHANG ; Li XU ; Le SHEN ; Yuguang HUANG
Medical Journal of Peking Union Medical College Hospital 2024;15(2):344-350
8.Study on the Application of Named Entity Recognition in Electronic Medical Records for Lymphedema Disease
Haocheng TANG ; Wanchun SU ; Xiuyuan JI ; Jianfeng XIN ; Song XIA ; Yuguang SUN ; Yi XU ; Wenbin SHEN
Journal of Medical Informatics 2024;45(2):52-58
Purpose/Significance The paper discusses the application of artificial intelligence technology to the key entity recognition ofunstructured text data in the electronic medical records of lymphedema patients.Method/Process It expounds the solution of model fine-tuning training under the background of sample scarcity,a total of 594 patients admitted to the department of lymphatic surgery of Beijing Shijitan Hospital,Capital Medical University are selected as the research objects.The prediction layer of the GlobalPointer model is fine-tuned according to 15 key entity categories labeled by clinicians,nested and non-nested key entities are identified with its glob-al pointer.The accuracy of the experimental results and the feasibility of clinical application are analyzed.Result/Conclusion After fine-tuning,the average accuracy rate,recall rate and Macro_F1 ofthe model are 0.795,0.641 and 0.697,respectively,which lay a foundation for accurate mining of lymphedema EMR data.
9.Research advances in application of the Milestones Evaluation System in training of resident anesthesiologists
Xia RUAN ; Xiaohan XU ; Lijian PEI ; Jie YI ; Gang TAN ; Yuguang HUANG
Chinese Journal of Medical Education Research 2024;23(12):1585-1590
In the field of standardized residency training for anesthesiologists in China, there is currently a lack of a formative evaluation system targeting the clinical competencies of residents. By searching the domestic and international literature on the application of the Milestones Evaluation System in standardized residency training of anesthesiologists, this article comprehensively reviews the background of competency-based medical education, the construction and development of the ACGME Milestones System in the United States, the design and establishment of Milestones Evaluation System in China, the application of Milestones Evaluation System in anesthesiology, and the issues that need to be noted in the implementation process. This review provides a useful reference for the application and promotion of Milestones Evaluation System in standardized residency training of anesthesiologists in China.
10.Research advances in application of the Milestones Evaluation System in training of resident anesthesiologists
Xia RUAN ; Xiaohan XU ; Lijian PEI ; Jie YI ; Gang TAN ; Yuguang HUANG
Chinese Journal of Medical Education Research 2024;23(12):1585-1590
In the field of standardized residency training for anesthesiologists in China, there is currently a lack of a formative evaluation system targeting the clinical competencies of residents. By searching the domestic and international literature on the application of the Milestones Evaluation System in standardized residency training of anesthesiologists, this article comprehensively reviews the background of competency-based medical education, the construction and development of the ACGME Milestones System in the United States, the design and establishment of Milestones Evaluation System in China, the application of Milestones Evaluation System in anesthesiology, and the issues that need to be noted in the implementation process. This review provides a useful reference for the application and promotion of Milestones Evaluation System in standardized residency training of anesthesiologists in China.

Result Analysis
Print
Save
E-mail